swisspartners Ltd. bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,178 shares of the medical research company’s stock, valued at approximately $277,000.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Jacobi Capital Management LLC lifted its stake in shares of Agilent Technologies by 80.0% in the fourth quarter. Jacobi Capital Management LLC now owns 225 shares of the medical research company’s stock worth $27,000 after buying an additional 100 shares in the last quarter. Jackson Grant Investment Advisers Inc. acquired a new stake in Agilent Technologies in the 4th quarter valued at about $33,000. Piscataqua Savings Bank purchased a new position in Agilent Technologies in the 1st quarter worth approximately $35,000. GPS Wealth Strategies Group LLC acquired a new position in shares of Agilent Technologies during the 1st quarter worth approximately $38,000. Finally, Allred Capital Management LLC purchased a new stake in shares of Agilent Technologies in the first quarter valued at approximately $44,000.
A number of equities analysts have weighed in on the company. Robert W. Baird boosted their price objective on Agilent Technologies from $137.00 to $144.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 26th. They noted that the move was a valuation call. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell upped their price objective on shares of Agilent Technologies from $150.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, May 26th. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $144.00 target price on the stock in a research note on Friday, May 28th. Wells Fargo & Company boosted their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a report on Wednesday, May 26th. Finally, Canaccord Genuity upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $85.00 to $100.00 in a report on Thursday, May 13th. Four equities research analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the company’s stock. Agilent Technologies presently has a consensus rating of “Buy” and an average price target of $113.69.
Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, May 24th. The medical research company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.82 by $0.15. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.39 billion. Agilent Technologies had a return on equity of 24.14% and a net margin of 15.90%. The firm’s revenue was up 23.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.71 earnings per share. On average, equities analysts forecast that Agilent Technologies, Inc. will post 4.12 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 28th. Stockholders of record on Tuesday, July 6th will be paid a dividend of $0.194 per share. This represents a $0.78 annualized dividend and a dividend yield of 0.55%. The ex-dividend date is Friday, July 2nd. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.78%.
Agilent Technologies declared that its board has approved a share buyback program on Tuesday, February 16th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the medical research company to repurchase up to 5% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its shares are undervalued.
In other news, VP Padraig Mcdonnell sold 1,000 shares of the firm’s stock in a transaction on Friday, May 28th. The shares were sold at an average price of $138.42, for a total value of $138,420.00. Following the transaction, the vice president now owns 16,916 shares of the company’s stock, valued at approximately $2,341,512.72. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Michael Tang sold 13,465 shares of the business’s stock in a transaction dated Thursday, May 27th. The stock was sold at an average price of $136.15, for a total value of $1,833,259.75. The disclosure for this sale can be found here. In the last ninety days, insiders sold 49,079 shares of company stock worth $6,544,104.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Recommended Story: How Do Tariffs Affect Trade Balances?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.